MedTrace Logo

Smoking Termination Opportunity for inPatients

NCT01141855 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 392

Last updated 2012-08-08

No results posted yet for this study

Summary

The Smoking Termination Opportunity for inPatients, (STOP) project is designed to capture the opportunity that is provided by admission for acute smoking related illness, to assist patients through withdrawal by use of a combination of:

* the new medication Champix with
* best practice counselling
* initiated in an inpatient setting

to achieve:

* sustained smoking abstinence
* reduced hospital bed and health service utilisation
* reduced inpatient smoking and craving prior to discharge

Conditions

  • Tobacco Use Disorder

Interventions

DRUG

Champix

Standard MIMS dosage (including period of titration) will be used. 0.5mg daily for 3 days 0.5mg b.d. for 4 days 1mb b.d. for 70 days (full course 3 months)

BEHAVIORAL

Counselling alone

Quit SA 5A counselling over the phone. Maximum 8 calls over a 3 month period

Sponsors & Collaborators

  • The Queen Elizabeth Hospital

    lead OTHER

Principal Investigators

  • Brian J Smith, MBBS; FRACP;PhD;Dip Clin Epid · The Queen Elizabeth Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01141855 on ClinicalTrials.gov